Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety of Non-MS Biologics in Patients with Multiple Sclerosis: A Multi-center Retrospective Study of MS Patients with Co-morbid Autoimmune Conditions

Author:Madill, Evan   Lenzi, Kerry   Galetta, Kristin   Lincoln, John   Longbrake, Erin   Von Geldern, Gloria   Sloane, Jacob   Coban, Hamza   Wallach, Asya   Gutman, Josef   Le, Nancy   Akers, Carolyn   Vij, Raveena   Bacon, Tamar   Naydovich, Laura   Pileggi, Caitlin   Xi, Jeffrey   de Freitas Dias, Bruna   Hobbs, Joshua   Balshi, Alexandra   Picone, Mary   Vonderhaar, Josephine   Kantor, Daniel   Bhattacharyya, Shamik   Kister, Ilya   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:General Neurology  

Program Number:S40.007  

Author Institution:

What Happens When Older MS Patients Stop Their Anti-CD20? A Two-center Retrospective Study

Author:Omari, Mirza   Wolf, Andrew   Alvarez, Enrique   Manini, Lyla   Corboy, John   Kister, Ilya   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Sleep  

Program Number:S40.008  

Author Institution:

A Case of Acute Necrotizing Encephalopathy in a Patient With Influenza

Author:Watkins, Kristen   Imossi, Catherine   Louie, Eddie   Thomas, Kristen   Methvin, Laura   William, Christopher   Kister, Ilya   Melmed, Kara   

Session Name:P2: Neurocritical Care: Case Reports  

Topic:Neuro-rehabilitation  

Program Number:P2.006  

Author Institution:

Tocilizumab as Add-on Therapy for Severe Attacks in NMOSD and MOGAD: A Multicenter Retrospective Case Series

Author:Flanagan, Eoin P.   Vilaseca, Andreu   Bilodeau, Philippe-Antoine   Filippatou, Angeliki G.   Jiang, Mulan   Said, Yana   Chen, Haiwen   Chen, John J.   Pittock, Sean J.   Sotirchos, Elias   Levy, Michael   Kister, Ilya   

Session Name:P3: Autoimmune Neurology: NMOSD/MOGAD 3  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P3.009  

Author Institution:

Multiple Sclerosis Disease Activity is Uncommon in Individuals With Pre-existing Multiple Sclerosis Exposed to Immune Checkpoint Inhibitor Therapy

Author:Gill, Alexander   Krett, Jonathan   Quinn, Carson   Rajarajan, Prashanth   Babcock, Lyndsey   Kaiser, Anna   Morrison, Andrew   Pisano, Thomas   Paracha, Atika   Dodson, Cory   Kopinsky, Hannah   Moninuola, Iwalewa   Alhassan, Said   Stewart, Wendy   Aguilera-Pena, Maria   Ramierz Guerrero, Sofia   Modak, Nikhil   Jean, Maxime   Lamb, Jessica   Piura, Yoav   CARRIER, Jordan   Arvas, Muhammed Ikbal   Camargo, Celeste   Bhise, Vikram   Linnoila, Jenny   Chaudhry, Vinay   Bhattacharyya, Shamik   Alvarez, Enrique   Kantor, Daniel   Nelsion, Flavia   Rammohan, Kottil   Coyle, Patricia   Hemminger, Lauryn   Baldwin, Nicole   Hutton, George   Simpson, Alexandra   Barreras, Paula   Dujmovic Basuroski, Irena   Harrington, Cole   Douglas, Anne   Day, Gregory   Kister, Ilya   Galetta, Kristin   Conway, Sarah   Roy, Shuvro   Gadani, Sachin   Wolf, Andrew   Probasco, John   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Education, Research, and Methodology  

Program Number:P4.002  

Author Institution: